Jump Financial »

Nektar Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.2M 53k 42.28

More positions owned by Jump Financial

iShares Russell 2000 ETF Etf (IWM)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
iShares 20 Year Treasury Bond ETF Etf (TLT)
NVIDIA Corp Common Stock (NVDA)
Walmart Common Stock (WMT)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Alphabet Common Stock (GOOGL)
Advanced Micro Devices Common Stock (AMD)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)
Alibaba Group Holding Convertible bond (Principal)
Boston Scientific Corp Common Stock (BSX)
Energy Transfer Partnership Shares (ET)

View all positions for Jump Financial

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Citadel Advisors
Two Seas Capital
BlackRock
Millennium Management
Prosight Management
Invesco
Point72 Asset Management
Sofinnova Ventures
Two Sigma Investments
Emerald Advisers
22NW
Qube Research & Technologies

View all funds holding Nektar Therapeutics